Kuhusu Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Makao makuu251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Ilianzishwa2018
HaliAmilifu
HatazaHataza 1
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Mapitio
Bado hakuna mapitio. Umefanya kazi na Assertio Therapeutics, Inc.? Kuwa wa kwanza kushiriki uzoefu wako.
Taarifa za kisheria
| Jina la kisheria | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Tazama kwenye GLEIF ↗ |
| Anwani iliyosajiliwa | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Hali | Amilifu |
Vyanzo: GLEIF · imesasishwa Okt. 16, 2026
Mawasiliano na viungo
Mahali
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Je, hii ni kampuni yako?
Dai ukurasa huu bure kuongeza nembo, bidhaa, picha na kazi zako, na kujibu mapitio.
Dai ukurasa huuJiunge na Heelky kuunganisha, kuajiri na kukua
Unda akaunti ya bure kutuma ujumbe kwa watu, kuomba kazi na kuchapisha misheni.
Jiunge sasa — ni bure